Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis

BACKGROUND: The prognosis of patients with combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma (CHC) is usually poor, and effective adjuvant therapy is missing making it important to investigate whether these patients may benefit from adjuvant transarterial chemoembolization (TACE)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Liu, Wei-Ren, Tian, Meng-Xin, Tao, Chen-Yang, Tang, Zheng, Zhou, Yu-Fu, Song, Shu-Shu, Jiang, Xi-Fei, Wang, Han, Zhou, Pei-Yun, Qu, Wei-Feng, Fang, Yuan, Ding, Zhen-Bin, Zhou, Jian, Fan, Jia, Shi, Ying-Hong
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7350756/
https://ncbi.nlm.nih.gov/pubmed/32650743
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07138-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados